Ipsen UK & Ireland

Ipsen U.K. and Ireland is a core part of Ipsen’s global biopharmaceutical business and is driven by the belief that patients don’t have time to wait. We have a biotech mindset coupled with pharmaceutical capabilities and have invested in a robust business presence that spans the early stages of research and development through to in-house manufacturing, so we can effectively deliver on our promise to patients. As part of this investment, we employ over 1,000 people across three sites, of which over 300 are based in London, home to one of our three Global Hubs alongside Paris, France and Cambridge in the U.S. At Ipsen, we focus on ensuring innovative solutions reach the people that need them most in oncology, rare disease and neuroscience. We push ourselves to address the most complex and difficult issues facing people’s health to deliver better outcomes. This purpose driven approach ensures we deliver real impact, in a sustainable way, for patients and society. Our Guidelines: The content available on this channel is for information purposes only. It is not intended to provide professional medical advice, diagnosis, or treatment. Always seek medical advice from your GP or a qualified healthcare professional. Ipsen is not responsible for third-party materials appearing on this channel. Ipsen does not control or endorse the third-party content and makes no representations regarding its accuracy. Ipsen values the insight and opinions of people who wish to take part in the LinkedIn community, however, we operate in a highly regulated environment. Please help us by not talking directly about specific products or named medicines. We will not moderate any comment, however, it may be necessary to remove comments if they mention medicines directly or could be offensive to people. If your post relates to an adverse event or product quality complaint related to a specific medication, the company may contact you to obtain further information. CRSC-GB-000200 | Jan 2025